Johnson & Johnson stock stays grounded. Focus turns to business context.
Published on 07/01/2026 at 16:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Christina Vaughn, Background & Management desk. Reviewed on July 1, 2026 at 2:12 p.m. ET.
Johnson & Johnson (US4781601046) is a global health-care company with operations in pharmaceuticals and MedTech, and its shares trade on the New York Stock Exchange. For investors, the main question remains how that mix of recurring demand and patent-driven drug revenue balances against execution in a mature, regulated industry.
Business breadth
The company operates through Innovative Medicine and MedTech, two segments that give it exposure to prescription drugs, surgical devices, and hospital systems. That structure matters because each unit reacts differently to pricing pressure, product launches, and clinical data.
US market context
Johnson & Johnson is a member of the Dow Jones Industrial Average, which keeps it firmly inside the US large-cap conversation. The stock also fits the profile of a defensive health-care name, a category that often draws attention when investors rotate toward earnings stability and dividend support.
Johnson & Johnson at a glance
The company combines pharmaceutical innovation with medical technology, giving it a broad operating base across hospitals, physicians, and patients.
Core product lines
Key products span immunology, oncology, neuroscience, cardiovascular care, and surgical systems. That mix is what makes Johnson & Johnson a representative health-care compounder rather than a single-product story.
Stock context
Johnson & Johnson shares trade on the NYSE and remain a widely followed US blue-chip name. As of July 1, 2026, 2:12 p.m. ET, the stock is not quoted here, leaving the company's operating mix and index membership as the clearest current frame.
Johnson & Johnson fact box
- Company: Johnson & Johnson
- ISIN: US4781601046
- Ticker: JNJ
- Exchange: NYSE
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Dow Jones Industrial Average
- Next earnings date: not yet officially scheduled
This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
